Suggestions(5)
Exact(5)
This group did not do as well clinically as the treated target mismatch patients despite more favourable baseline imaging (Supplementary Table 1).
Other possible explanations might be that the male patients with an eGFR >60 ml/min generally had a more favourable baseline risk profile compared with the female patients with an eGFR >60 ml/min.
Longer median PFS and OS were associated with higher (more favourable) baseline FKSI-15, FKSI-DRS, and FACT-G scores (each P<0.05 from the Weibull model) in patients on sunitinib or IFN- α.
However, the 60 patients without visually large cores had more favourable baseline imaging characteristics than treated target mismatch (smaller cores and smaller perfusion lesions), yet still had a worse outcome than the treated target mismatch group.
These peculiarities could support a thesis that part of the benefit observed in terms of PFS could be related to the more favourable baseline conditions of the enrolled population.
Similar(55)
Increased median PFS and OS were associated with higher (better or more favourable; fewer symptoms) baseline FKSI-15 scores in patients on sunitinib or IFN- α.
Coefficients greater than 1 indicate that the women in the intervention clusters within that demographic subgroup had a more favourable distribution compared to the baseline category which was over and above any increase in favourable practices that could be attributed to intervention across all subgroups.
Nevertheless, our analysis has shown that the health effect is higher and the cost-effectiveness is more favourable in subgroups at high cardiovascular baseline risk.
In contrast, patients without renal impairment at baseline had a more favourable outcome post-treatment (no clinical events, renal function remained unchanged, and PWT decreased significantly).
Two years after baseline, we found more favourable scores on the loneliness literacy subscales, motivation, perceived social support, and subjective norm (initial outcomes), in the intervention group as compared to the control group.
From our observations, it seems that response to infliximab is more favourable under higher numbers of this cell type at baseline.
More suggestions(15)
more favourable direction
more balanced baseline
more favourable tax
more favourable picture
more incomplete baseline
more advanced baseline
more favourable state
more refined baseline
more favourable verdict
more pronounced baseline
more detailed baseline
more stable baseline
more reasonable baseline
more favourable product
more elevated baseline
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com